» Articles » PMID: 38967898

Infectious Mononucleosis Complicated by Transitory Epstein-Barr Virus Infection of T and Natural Killer Cells

Overview
Journal J Hematop
Publisher Springer
Specialty Hematology
Date 2024 Jul 5
PMID 38967898
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) typically infects B cells in infectious mononucleosis (IM), but a rare case shows EBV infection in T cells. Seven cases of lymphoproliferative disorder caused by EBV-positive cytotoxic T/natural killer (NK) cell proliferation in the lymph nodes, termed IM with transient EBV infection of T and NK cells (EBV + T/NK cells in IM), are reported here. The purpose of the study is to describe clinicopathological features of EBV + T/natural killer (NK) cells in IM of the lymph node. We retrospectively analysed seven cases of Chinese children and young people adults with EBV + T/NK cells in IM. We used morphological observation, immunohistochemical staining, EB virus in situ hybridisation detection, and analysis of T-cell receptor gene rearrangement. The patients were healthy prior to illness, experiencing sudden onset occurring in all the patients, with high fever as the first symptom, followed by lymphadenopathy and hepatosplenomegaly. Diagnosis occurred < 1.5 months of symptom onset. Most lymphocytes in lesions expressed CD3 and Granzyme B or TIA-1 and lacked CD5. CD56 was expressed in numerous cells in 5 of the 7 cases. EBV-encoded RNA (EBER) was detected in medium-to-large-sized cells (50-100 cells per cell/high-power field). T-cell receptor (TCR) gene rearrangement was seen in six cases, with monoclonal rearrangement in four cases. Treatment was conservative treatment but not chemotherapy. Four received anti-HLH therapy and others anti-inflammatory treatment. All patients survived with relapse after long-term clinical observation and follow-up. EBV + T/NK cells in IM can elicit malignant features that mimic T/NK-cell lymphoma pathologically and benign features mimicking IM clinically. These findings indicate that EBV + T/NK cells in IM could serve as valuable diagnosis. Additional clinical information, including age of onset (children and young people), nature of onset (sudden), disease course (short), symptoms (systemic), EBV infection status (acute), and lymph node involvement, is crucial for accurate diagnosis and prognostic evaluation.

References
1.
Kim S, Oh S, Hong J, Chang M, Lee D, Huh J . When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?. Ann Oncol. 2009; 21(5):1058-63. DOI: 10.1093/annonc/mdp412. View

2.
Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma D . Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000; 96(2):443-51. View

3.
Epstein M, ACHONG B, BARR Y . VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet. 1964; 1(7335):702-3. DOI: 10.1016/s0140-6736(64)91524-7. View

4.
Jeon Y, Kim J, Sung J, Han J, Ko Y . Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015; 46(7):981-90. DOI: 10.1016/j.humpath.2015.03.002. View

5.
Lee H, Baek J, Lee J, Park S, Jeon I, Roh J . Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder. Am J Dermatopathol. 2012; 34(8):e119-24. DOI: 10.1097/DAD.0b013e3181c036de. View